Boston, MA -- (SBWIRE) -- 01/17/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Glu Mobile Inc.(NASDAQ:GLUU), JA Solar Holdings Co., Ltd. (ADR)(NASDAQ:JASO), Keryx Biopharmaceuticals(NASDAQ:KERX), Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN)
Glu Mobile Inc.(NASDAQ:GLUU) opened its shares at the price of $4.04 for the day. Its closing price was $3.92 after losing -2.97% for the day. The company traded with the total volume of 4.11 million shares, while its average trading volume remained 2.70 million shares. The beta of GLUU stands at 1.73. Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices.
Has GLUU Found The Bottom and Ready To Move Up? Find Out Here
JA Solar Holdings Co., Ltd. (ADR)(NASDAQ:JASO) percentage change surged +6.79% to close at $10.07 with the total traded volume of 3.99 million shares, and average volume of 2.15 million. The 52 week range of the stock remained $3.37 - $12.80, while its day lowest price was $9.51 and it hit its day highest price at $10.17. JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the design, development, production, marketing, and sale of solar power products based on crystalline silicon technologies.
For How Long JASO’s Gloss will Attract Investors ? Find out via this report
Keryx Biopharmaceuticals(NASDAQ:KERX) started its trading session with the price of $13.59 and closed at $14.24 by scoring +4.63%. KERX’s stocks traded with total volume of 3.97 million shares, while the average trading volume remained 2.40 million shares. The beta of KERX stands at 3.92. Day range of the stock was $13.56 -$14.58. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Will KERX Continue To Move Higher? Find Out Here
Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN) ended its day with the gain of +6.70% and closed at the price of $3.98 after opening at $3.73. Stock traded during its last trading session with the total volume of 3.91 million shares, as compared to its average volume of 2.15 million shares. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.
Why Should Investors Buy ACHN After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)